Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a disease topic and introduced a Resources section with the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-30T16:27:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-23T13:27:13.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Layout and navigation appear adjusted between the two screenshots, while core study sections such as endpoints, eligibility criteria, and enrollment show no visible changes.
    Difference
    0.0%
    Check dated 2026-03-16T03:27:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No other visible changes to content or layout on the Study Details page.
    Difference
    0.1%
    Check dated 2026-03-09T00:30:16.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a label 'Revision: v3.4.2' to the page. The previous 'Revision: v3.4.1' label is no longer displayed.
    Difference
    0.0%
    Check dated 2026-02-15T15:07:53.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added in the page footer, replacing v3.4.0. This is a minor UI update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T09:29:38.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.